Search
Search Results
##search.searchResults.foundPlural##
-
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3287PDF: 1308HTML: 6187 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7903PDF: 4091HTML: 7345 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3018PDF: 1022HTML: 3071 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3360PDF: 1277HTML: 2212Fi.1 Gritti.Rambaldi: 203 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4710PDF: 1546HTML: 2251Untitled: 205Untitled: 220Untitled: 228Untitled: 210Untitled: 212 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2526PDF: 866HTML: 2120 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2832PDF: 1218HTML: 2696Figure 1: 168 -
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
1913PDF: 1091HTML: 1890Lung computed tomography CT scan image: 200 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3241PDF: 1707HTML: 1082 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2059PDF: 1507HTML: 274 -
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
143PDF: 161Suppl. Files: 32HTML: 11 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1919PDF: 1159HTML: 265 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
716PDF: 463HTML: 6263 -
SERO PREVALENCE OF TOXARA CANIS IN THE CITY OF CATANIA, ITALY.
1354PDF: 939HTML: 219 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6794PDF: 3638HTML: 750 -
-
Early Diagnosis of Gaucher Disease and ASMD in Sardinia: the “ICHNOS” Project
608PDF: 484Suppl. Files: 125Html: 124 -
HIV AND LYMPHOMA: FROM EPIDEMIOLOGY TO CLINICAL MANAGEMENT Guest Editors: Mario Luppi and Luca Arcaini
3520PDF: 2176HTML: 363 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1581PDF: 969HTML: 183







